EDGAR Filing Documents for 0001600132-20-000032

Form 8-K - Current report:

SEC Accession No. 0001600132-20-000032

Filing Date

2020-03-31

Accepted

2020-03-31 13:28:06

Documents

Period of Report

2020-03-31

Items

Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	a8-kmarch2020covidx19webin.htm	8-K	33729
2	EXHIBIT 99.1	bellerophoncovid19deckma.htm	EX-99.1	25389
3		bellerophoncovid19deckma001.jpg	GRAPHIC	119469
4		bellerophoncovid19deckma002.jpg	GRAPHIC	148160
5		bellerophoncovid19deckma003.jpg	GRAPHIC	97084
6		bellerophoncovid19deckma004.jpg	GRAPHIC	90528
7		bellerophoncovid19deckma005.jpg	GRAPHIC	107349
8		bellerophoncovid19deckma006.jpg	GRAPHIC	86874
9		bellerophoncovid19deckma007.jpg	GRAPHIC	77395
10		bellerophoncovid19deckma008.jpg	GRAPHIC	115478
11		bellerophoncovid19deckma009.jpg	GRAPHIC	98309
12		bellerophoncovid19deckma010.jpg	GRAPHIC	108562
13		bellerophoncovid19deckma011.jpg	GRAPHIC	108598
14		bellerophoncovid19deckma012.jpg	GRAPHIC	87450
15		bellerophoncovid19deckma013.jpg	GRAPHIC	97230
16		bellerophoncovid19deckma014.jpg	GRAPHIC	71691
17		bellerophoncovid19deckma015.jpg	GRAPHIC	101869
18		bellerophoncovid19deckma016.jpg	GRAPHIC	127547
	Complete submission text file	0001600132-20-000032.txt		2325686

Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059

Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770

Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)